American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.

Ryan M. Daniel

Ryan M. Daniel

Chief Patent Counsel
Fresenius Kabi USA, LLC (Lake Zurich, IL)


Guy Donatiello

Senior Vice President, Intellectual Property
Endo Pharmaceuticals (Malvern, PA)


Stephanie Donahue

Senior Director, Patent Litigation
Sanofi (Bridgewater, NJ)

Rekha Hanu, Ph.D, J.D

Executive Director, Chief IP Counsel
Akorn Pharmaceuticals (Lake Forest, IL)


Staci Julie

SVP and Chief IP Counsel
Teva Pharmaceuticals (Horsham, PA)

Andrea Hutchison

Andrea Hutchison

Senior Associate General Counsel, IP Litigation
Gilead Sciences (Foster City, CA)


James P. Leeds

Assistant General Patent Counsel
Eli Lilly & Company (Indianapolis, IN)

James Kellerman

Senior Vice President, Intellectual Property
Astellas Pharma US, Inc. (Northbrook, IL)


Josephine Liu, Ph.D., J.D.

Vice President of IP, North America (ad interim)
Sandoz Inc. (Princeton, NJ)


Jeffrey N. Myers, Ph.D.

Vice President & Assistant General Counsel
Pfizer Inc (New York, NY)


Mary Morry

Merck & Company (Rahway, NJ)


Pearl T. L. Siew

Senior Vice President and Head Intellectual Property
Eagle Pharmaceuticals, Inc (Woodcliff Lake, NJ)


Lars Taavola

VP, Chief Intellectual Property Counsel
Mallinckrodt Pharmaceuticals (Bedminster, NJ)

Brian Stone

Vice President Assistant Global General
Counsel Regulatory
Mylan (Washington, DC)


Peter Waibel

Head, US Patent Litigation
Novartis Pharmaceuticals Corporation (East Hanover, NJ)

Kevin Zive

Vice President – Global Intellectual Property and Legal Affairs
Apotex Inc. (Toronto, CA)

Emeritus Members


Stephen R. Auten

Partner, Chair of Pharmaceutical & Life Sciences Litigation
Taft Stettinius & Hollister LLP (Chicago, IL)
(Former Vice President, IP, Sandoz, Inc.)


George W. Johnston

Gibbons P.C. (Newark, NJ)
(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)


David H. Silverstein, M.S., J.D.

Axinn, Veltrop & Harkrider LLP (New York, NY)
(Former Senior Director, Intellectual Property, Par Pharmaceutical, Inc)


Meg Snowden

Margaret M. Snowden, P.C. (San Francisco, CA)
(Former Vice President,, Intellectual Property, Impax Laboratories)


Shashank Upadhye

Upadhye Cwik LLP (Chicago, IL)
(Former Vice President – Global Intellectual Property, Apotex, Inc.)